BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 32397824)

  • 1. Cross-validation of non-memory-based embedded performance validity tests for detecting invalid performance among patients with and without neurocognitive impairment.
    White DJ; Korinek D; Bernstein MT; Ovsiew GP; Resch ZJ; Soble JR
    J Clin Exp Neuropsychol; 2020 Jul; 42(5):459-472. PubMed ID: 32397824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-validation of the Trail Making Test as a non-memory-based embedded performance validity test among veterans with and without cognitive impairment.
    Peak AM; Marceaux JC; Chicota-Carroll C; Soble JR
    J Clin Exp Neuropsychol; 2024 Feb; 46(1):16-24. PubMed ID: 38007610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Not so fast! Limitations of processing speed and working memory indices as embedded performance validity tests in a mixed neuropsychiatric sample.
    Ovsiew GP; Resch ZJ; Nayar K; Williams CP; Soble JR
    J Clin Exp Neuropsychol; 2020 Jul; 42(5):473-484. PubMed ID: 32498648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing the Psychometric Properties of Eight Embedded Performance Validity Tests in the Rey Auditory Verbal Learning Test, Wechsler Memory Scale Logical Memory, and Brief Visuospatial Memory Test-Revised Recognition Trials for Detecting Invalid Neuropsychological Test Performance.
    Pliskin JI; DeDios Stern S; Resch ZJ; Saladino KF; Ovsiew GP; Carter DA; Soble JR
    Assessment; 2021 Dec; 28(8):1871-1881. PubMed ID: 32484371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing performance validity during attention-deficit/hyperactivity disorder evaluations: Cross-validation of non-memory embedded validity indicators.
    Ausloos-Lozano JE; Bing-Canar H; Khan H; Singh PG; Wisinger AM; Rauch AA; Ogram Buckley CM; Petry LG; Jennette KJ; Soble JR; Resch ZJ
    Dev Neuropsychol; 2022 Aug; 47(5):247-257. PubMed ID: 35787068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of various WAIS-IV Digit Span indices for identifying noncredible performance validity among cognitively impaired and unimpaired examinees.
    Webber TA; Soble JR
    Clin Neuropsychol; 2018 May; 32(4):657-670. PubMed ID: 29256334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive impairment does not cause invalid performance: analyzing performance patterns among cognitively unimpaired, impaired, and noncredible participants across six performance validity tests.
    Critchfield E; Soble JR; Marceaux JC; Bain KM; Chase Bailey K; Webber TA; Alex Alverson W; Messerly J; Andrés González D; O'Rourke JJF
    Clin Neuropsychol; 2019 Aug; 33(6):1083-1101. PubMed ID: 30475095
    [No Abstract]   [Full Text] [Related]  

  • 8. The Word Memory Test genuine memory impairment profile discriminates genuine memory impairment from invalid performance in a mixed clinical sample with cognitive impairment.
    Alverson WA; O'Rourke JJF; Soble JR
    Clin Neuropsychol; 2019 Nov; 33(8):1420-1435. PubMed ID: 31002017
    [No Abstract]   [Full Text] [Related]  

  • 9. Multivariable analysis of the relative utility and additive value of eight embedded performance validity tests for classifying invalid neuropsychological test performance.
    Jennette KJ; Rhoads T; Resch ZJ; Cerny BM; Leib SI; Sharp DW; Ovsiew GP; Soble JR
    J Clin Exp Neuropsychol; 2022 Sep; 44(7):451-460. PubMed ID: 36197342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-validation of three Advanced Clinical Solutions performance validity tests: Examining combinations of measures to maximize classification of invalid performance.
    Bain KM; Soble JR; Webber TA; Messerly JM; Bailey KC; Kirton JW; McCoy KJM
    Appl Neuropsychol Adult; 2021; 28(1):24-34. PubMed ID: 30987451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimizing evaluation time while maintaining accuracy: Cross-validation of the Test of Memory Malingering (TOMM) Trial 1 and first 10-item errors as briefer performance validity tests.
    Kraemer LDR; Soble JR; Phillips JI; Webber TA; Fullen CT; Highsmith JM; Alverson WA; Critchfield EA
    Psychol Assess; 2020 May; 32(5):442-450. PubMed ID: 32027161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired or invalid? Limitations of assessing performance validity using the Boston Naming Test.
    Abramson DA; Resch ZJ; Ovsiew GP; White DJ; Bernstein MT; Basurto KS; Soble JR
    Appl Neuropsychol Adult; 2022; 29(4):486-491. PubMed ID: 32538174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Every second counts: A comparison of four dot counting test scoring procedures for detecting invalid neuropsychological test performance.
    Rhoads T; Resch ZJ; Ovsiew GP; White DJ; Abramson DA; Soble JR
    Psychol Assess; 2021 Feb; 33(2):133-141. PubMed ID: 33119378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the accuracy of the Wechsler Memory Scale-Fourth Edition (WMS-IV) logical memory embedded validity index for detecting invalid test performance.
    Soble JR; Bain KM; Bailey KC; Kirton JW; Marceaux JC; Critchfield EA; McCoy KJM; O'Rourke JJF
    Appl Neuropsychol Adult; 2019; 26(4):311-318. PubMed ID: 29308933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Direct Comparison of 10 WAIS-IV Digit Span Embedded Validity Indicators among a Mixed Neuropsychiatric Sample with Varying Degrees of Cognitive Impairment.
    Resch ZJ; Cerny BM; Ovsiew GP; Jennette KJ; Bing-Canar H; Rhoads T; Soble JR
    Arch Clin Neuropsychol; 2023 May; 38(4):619-632. PubMed ID: 36244241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using the Grooved Pegboard Test as an Embedded Validity Indicator in a Mixed Neuropsychiatric Sample with Varying Cognitive Impairment: Cross-Validation Problems.
    Chang F; Cerny BM; Tse PKY; Rauch AA; Khan H; Phillips MS; Fletcher NB; Resch ZJ; Ovsiew GP; Jennette KJ; Soble JR
    Percept Mot Skills; 2023 Apr; 130(2):770-789. PubMed ID: 36634223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of race and other demographic factors on the false positive rates of five embedded Performance Validity Tests (PVTs) in a Veteran sample.
    Denning JH; Horner MD
    J Clin Exp Neuropsychol; 2024 Feb; 46(1):25-35. PubMed ID: 38353039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Examining independent and combined accuracy of embedded performance validity tests in the California Verbal Learning Test-II and Brief Visuospatial Memory Test-Revised for detecting invalid performance.
    Resch ZJ; Pham AT; Abramson DA; White DJ; DeDios-Stern S; Ovsiew GP; Castillo LR; Soble JR
    Appl Neuropsychol Adult; 2022; 29(2):252-261. PubMed ID: 32202916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examination of optimal embedded PVTs within the BVMT-R in an outpatient clinical sample.
    Olsen DH; Schroeder RW; Heinrichs RJ; Martin PK
    Clin Neuropsychol; 2019 May; 33(4):732-742. PubMed ID: 30354925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specificity of Embedded Performance Validity Tests in Elderly Veterans with Mild and Major Neurocognitive Disorder.
    Kanser RJ; Logan PM; Steward KA; Vanderbleek EN; Kamper JE
    Arch Clin Neuropsychol; 2023 Jul; 38(5):772-781. PubMed ID: 36578198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.